As of 9:30:33 AM EST. Market Open.
Breakdown
TTM
9/30/2022
9/30/2021
9/30/2020
Operating Cash Flow
1,618.8220
-601.1700
-1,429.1890
-3,540.7380
Investing Cash Flow
--
--
527.0000
491.7020
Financing Cash Flow
-1,624.1970
592.3830
736.7020
3,126.8760
End Cash Position
-0.8680
15.7720
24.5590
190.0460
Capital Expenditure
-80.6340
--
--
-80.6340
Issuance of Capital Stock
1,695.0820
--
500.0000
1,695.0820
Issuance of Debt
-1,624.1970
592.3830
--
1,671.6140
Repayment of Debt
--
--
-300.0000
-136.2290
Free Cash Flow
1,618.8220
-601.1700
-1,429.1890
-3,621.3720
9/30/2020 - 6/17/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
29A.SG Amphastar Pharmaceuticals Inc
34.66
-0.14%
27N0.DU Cannovum Cannabis AG
0.4980
0.00%
068760.KQ Celltrion Pharm, Inc.
56,900.00
-1.22%
0ET.MU Esperion Therapeutics Inc
2.1410
0.00%
RIG2.BE Chemical Works of Gedeon Richter PLC
25.16
-0.55%
11L.MU Canopy Growth Corp. R
2.4700
-4.26%
R9U2.F Green Thumb Industries Inc.
7.42
+2.77%
KN0.F Dicot Pharma AB
0.0282
+20.00%
CEL.L Celadon Pharmaceuticals Plc
16.00
0.00%
9989.HK Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3.640
-2.93%